D. E. Shaw & Co., Inc. Omeros Corp Transaction History
D. E. Shaw & Co., Inc.
- $122 Billion
- Q4 2024
A detailed history of D. E. Shaw & Co., Inc. transactions in Omeros Corp stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 1,838,898 shares of OMER stock, worth $17.7 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,838,898
Previous 1,605,240
14.56%
Holding current value
$17.7 Million
Previous $6.37 Million
185.12%
% of portfolio
0.01%
Previous 0.01%
Shares
30 transactions
Others Institutions Holding OMER
# of Institutions
142Shares Held
26.9MCall Options Held
959KPut Options Held
732K-
Black Rock Inc. New York, NY4.1MShares$39.4 Million0.0% of portfolio
-
Ingalls & Snyder LLC New York, NY4.01MShares$38.5 Million1.55% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.14MShares$30.2 Million0.0% of portfolio
-
Stifel Financial Corp St. Louis, MO1.58MShares$15.2 Million0.02% of portfolio
-
Geode Capital Management, LLC Boston, MA1.34MShares$12.9 Million0.0% of portfolio
About OMEROS CORP
- Ticker OMER
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,730,000
- Market Cap $603M
- Description
- Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...